CMS’ VBID Plans Raise Questions on Patient Choice, Meaning of ‘Concurrent Care’

Posted April 12, 2023

As CMS extends the Medicare Advantage hospice carve-in through 2023, providers are worried about keeping patient choice and the nature of concurrent care.  CMS recently extended the hospice component of the value-based insurance design model (VBID) which was scheduled to be completed in 2024. The agency announced that patients will be able to receive curative treatments in tandem with hospice care and that it would permit health plans to further restrict the utilization of out-of-network providers.

The possibility of plans closing their networks raises questions about patients’ ability to choose who provides their hospice care, according to Mike Smith, CEO of Hospice of Iredell County.  “As it currently stands a patient can choose whichever hospice they want when they elect hospice care. Narrowing that choice by creating a network could potentially reduce the pool of high-quality options for the patient depending on what criteria are used for inclusion,” Smith told Hospice News. “Another issue is the monopolistic concept of ‘pay-viders’, where the payer is also the provider. The concern is that the only providers in the network will be those owned by payers. This, by default, reduces patient choice.”

Click here for the full article.

About Corridor

For over 30 years, Corridor has partnered with home health and hospice providers, delivering powerful solutions to support the unique challenges of caring for patients in the home. Our team of operations executives, clinicians, and nationally renowned industry experts have run provider organizations and resolved the same challenges you face.

To receive the most important industry updates, insights and news impacting home health and hospice, please make sure to sign up for our weekly newsletter.

Explore Corridor’s Solutions

Share This Story, Choose Your Platform!